TY - JOUR
T1 - Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment
T2 - the ATTICA epidemiological cohort study (2002–2012)
AU - Georgoulis, Michael
AU - Chrysohoou, Christina
AU - Georgousopoulou, Ekavi
AU - Damigou, Evangelia
AU - Skoumas, Ioannis
AU - Pitsavos, Christos
AU - Panagiotakos, Demosthenes
N1 - Funding Information:
The ATTICA study was supported by research grants from the Hellenic Society of Cardiology [HCS2002] and the Hellenic Atherosclerosis Society [HAS2003]. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12/19
Y1 - 2022/12/19
N2 - Background: The link between blood lipids and cardiovascular disease (CVD) is complex. Our aim was to assess the differential effect of blood lipids on CVD risk according to age, sex, body weight, diet quality, use of lipid-lowering drugs and presence of hypercholesterolemia. Methods: In this secondary analysis of the ATTICA prospective cohort study, serum blood lipids, i.e., total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and liproprotein(a) [Lp(a)], and sociodemographic, anthropometric, lifestyle and clinical parameters were evaluated at baseline (2001/2002) in 2020 CVD-free men and women. CVD incidence was recorded at the 10-year follow-up (2011/2012). Results: All blood lipids assessed were univariately related to CVD risk; however, associations remained significant only for HDL-C and TG in multivariate models adjusted for age, sex, body mass index, smoking, Mediterranean Diet Score, physical activity, presence of hypercholesterolemia, hypertension and diabetes mellitus, use of lipid-lowering drugs, and family history of CVD [RR per 1 mg/dL (95% CI): 0.983 (0.967, 1.000) and 1.002 (1.001, 1.003), respectively]. In stratified analyses, TC and LDL-C predicted CVD risk in younger subjects, normal-weight subjects, and those not on lipid-lowering drugs, while HDL-C and TG were significant predictors in older subjects, those with low adherence to the Mediterranean diet, and hypercholesterolemic subjects; a significant effect on CVD risk was also observed for TG in males, overweight participants and lipid-lowering medication users and for Lp(a) in older subjects and females (all p ≤ 0.050). Conclusions: The impact of blood lipids on CVD risk differs according to several biological, lifestyle and clinical parameters.
AB - Background: The link between blood lipids and cardiovascular disease (CVD) is complex. Our aim was to assess the differential effect of blood lipids on CVD risk according to age, sex, body weight, diet quality, use of lipid-lowering drugs and presence of hypercholesterolemia. Methods: In this secondary analysis of the ATTICA prospective cohort study, serum blood lipids, i.e., total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and liproprotein(a) [Lp(a)], and sociodemographic, anthropometric, lifestyle and clinical parameters were evaluated at baseline (2001/2002) in 2020 CVD-free men and women. CVD incidence was recorded at the 10-year follow-up (2011/2012). Results: All blood lipids assessed were univariately related to CVD risk; however, associations remained significant only for HDL-C and TG in multivariate models adjusted for age, sex, body mass index, smoking, Mediterranean Diet Score, physical activity, presence of hypercholesterolemia, hypertension and diabetes mellitus, use of lipid-lowering drugs, and family history of CVD [RR per 1 mg/dL (95% CI): 0.983 (0.967, 1.000) and 1.002 (1.001, 1.003), respectively]. In stratified analyses, TC and LDL-C predicted CVD risk in younger subjects, normal-weight subjects, and those not on lipid-lowering drugs, while HDL-C and TG were significant predictors in older subjects, those with low adherence to the Mediterranean diet, and hypercholesterolemic subjects; a significant effect on CVD risk was also observed for TG in males, overweight participants and lipid-lowering medication users and for Lp(a) in older subjects and females (all p ≤ 0.050). Conclusions: The impact of blood lipids on CVD risk differs according to several biological, lifestyle and clinical parameters.
KW - Cardiovascular risk
KW - Dyslipidemia
KW - High-density lipoprotein cholesterol
KW - Hyperlipidemia
KW - Lipidemic profile
KW - Lipoprotein(a)
KW - Low-density lipoprotein cholesterol
KW - Triglycerides
UR - http://www.scopus.com/inward/record.url?scp=85144286831&partnerID=8YFLogxK
U2 - 10.1186/s12944-022-01747-2
DO - 10.1186/s12944-022-01747-2
M3 - Article
C2 - 36529737
AN - SCOPUS:85144286831
SN - 1476-511X
VL - 21
SP - 1
EP - 13
JO - Lipids in Health and Disease
JF - Lipids in Health and Disease
IS - 1
M1 - 141
ER -